为了观察血脂康治疗脂肪肝的临床效果,本科于1997年3～8月对26例患者进行了临床观察,结果报告如下。 一、临床资料 1.观察对象: 入选患者26例,均由B超诊断为脂肪肝,伴有或不伴有肝功能异常及高脂血症,排除甲、乙、丙型肝炎;其中各有1例为胆囊多发息肉和胆囊炎。男18例,平均年龄43.73±7.94岁; In order to observe the clinical effect of Xuezhikang in the treatment of fatty liver, we conducted clinical observation on 26 patients from March to August in 1997. The results are reported as follows. First, the clinical data 1.Objective: Selected patients in 26 cases were diagnosed by B ultrasound as fatty liver, with or without liver dysfunction and hyperlipidemia, excluding A, B and C; each of which has 1 case of multiple gallbladder polyps and cholecystitis. 18 males, average age 43.73 ± 7.94 years;